Talk:CD134

Physiology Mid‑importance

	This article is within the scope of WikiProject Physiology, a collaborative effort to improve the coverage of Physiology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PhysiologyWikipedia:WikiProject PhysiologyTemplate:WikiProject PhysiologyPhysiology articles
Mid	This article has been rated as Mid-importance on the importance scale.
	This article has been classified as relating to the physiology of cells.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Assessment comment[edit]

The comment(s) below were originally left at Talk:CD134/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Would an anti-CD134 monoclonal antibody or immunoconjugate allow for

selective destruction of RECENTLY activated T-cells ? If this is the case, presumably it could have many potential implications including Tx of graft-versus-host disease, and various new-onset T-cell mediated autoimmune diseases.

Any thoughts or info ?

Last edited at 08:33, 20 February 2007 (UTC). Substituted at 10:39, 29 April 2016 (UTC)

Could mention study of OX40 agonists eg to boost immunotherapy[edit]

When I get time. - Rod57 (talk) 12:34, 4 December 2017 (UTC)[reply]